Chimerix Inc

NASDAQ:CMRX   3:59:57 PM EDT
5.34
+0.09 (+1.71%)
Products

Chimerix Announces FDA Acceptance Of New Drug Application For Brincidofovir As A Medical Countermeasure For Smallpox

Published: 12/07/2020 12:26 GMT
Chimerix Inc (CMRX) - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir As a Medical Countermeasure for Smallpox.
Chimerix Inc - FDA Granted Priority Review and Set Action Date of April 7, 2021 Under PDUFA.